isoxazoles has been researched along with Lymphoma, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, VK; Kumar, A | 1 |
| Griffiths, M; Keast, D | 1 |
2 other study(ies) available for isoxazoles and Lymphoma, T-Cell
| Article | Year |
|---|---|
Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.
Topics: Apoptosis; Glycolysis; Humans; Immunity; Isoxazoles; Lymphoma, T-Cell; Lysophospholipids; Propionates; Receptors, Lysophosphatidic Acid | 2022 |
The effects of a leukaemia-controlling dose of acivicin on murine splenic lymphocytes in vitro and in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; DNA, Neoplasm; Drug Resistance; Female; Immunoglobulin M; In Vitro Techniques; Isoxazoles; Leukemia, Experimental; Lymphocytes; Lymphoma, T-Cell; Mice; Mice, Inbred BALB C; Spleen | 1991 |